Nicholas Investment Partners, LP

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1389574 RANCHO SANTA FE, CA

Position in MIRM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,217,403

+$8,087,632 QoQ

Shares Held

172,695

+31.5% QoQ

Ownership

0.266%

of shares outstanding

% of Portfolio

1.30%

of 13F equity value

Holder Rank

#71

of 326 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names. MIRM ranks #5 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	244,594	$45,807,564
2	AXSM	Axsome Therapeutics, Inc.	98,974	$24,225,865
3	XENE	Xenon Pharmaceuticals Inc.	395,844	$23,893,143
4	BBIO	BridgeBio Pharma, Inc.	311,494	$23,200,073
5	MIRM	Mirum Pharmaceuticals, Inc. This page	172,695	$20,217,403
6	ELVN	Enliven Therapeutics, Inc.	391,529	$19,870,096
7	DNTH	Dianthus Therapeutics, Inc. /DE/	186,769	$18,206,242
8	CYTK	Cytokinetics Inc	209,071	$17,810,758

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,217,403	172,695	+31.5%	Shares	Sole	2026-08-14
2026-03-31	$12,129,771	131,303	-38.5%	Shares	Sole	2026-05-15
2025-12-31	$16,855,755	213,391	-1.7%	Shares	Sole	2026-02-13
2025-09-30	$15,913,255	217,068	+17.7%	Shares	Sole	2025-11-14
2025-06-30	$9,388,339	184,483	+6.6%	Shares	Sole	2025-08-14
2025-03-31	$7,795,587	173,043	+16.3%	Shares	Sole	2025-05-15
2024-12-31	$6,154,658	148,843	+3.0%	Shares	Sole	2025-02-14
2024-09-30	$5,634,681	144,479	-4.3%	Shares	Sole	2024-11-12
2024-03-31	$3,793,170	151,002	-62.1%	Shares	Sole	2024-05-14
2023-12-31	$11,775,026	398,883	-66.7%	Shares	Sole	2024-02-08
2023-09-30	$37,899,965	1,199,366	+31.1%	Shares	Sole	2023-11-13
2023-06-30	$23,674,128	915,119	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.